Bio-Techne Corp at Wells Fargo Healthcare Conference Transcript
All right. Great. Thank you, everybody, for being here. This is Tim Daley, Life Science Tools, Diagnostics and Pharma Services Analyst here at Wells Fargo. Welcome to the Healthcare Conference 2023 here in Boston. I'm pleased to have Bio-Techne here with us. We've got Jim Hippel, CFO; and David Clair, Investor Relations here with us on the stage. And we have a bunch of questions for them, a lot of hot topics that currently are on top of mind as well as on top of other companies' minds. And I'll probably leave a little bit of time at the end for Q&A. But just to, I guess, kick it off with the hot topic du jour, any update for us on August? How are things trending versus July, month-to-month volatility has been all over the place depending on end market, geographical market, any changes specifically?
Honestly, really nothing, no changes to report on since kind of the view we shared at our last
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |